apo-omeprazole 20mg capsules delayed-release
apotex inc. - omeprazole - capsules delayed-release - 20mg
apo-sucralfate 1000mg tablets
apotex inc. - sucralfate - tablets - 1000mg
apo-omeprazole capsules delayed-release
apotex inc. - omeprazole - capsules delayed-release - 20mg
gabapentin capsule
blenheim pharmacal, inc. - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 300 mg - gabapentin is indicated for the management of postherpetic neuralgia in adults. gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. gabapentin is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 to 12 years. gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. controlled substance gabapentin is not a scheduled drug. abuse gabapentin does not exhibit affinity for benzodiazepine, opiate (mu, delta or kappa), or cannabinoid 1 receptor sites. a small number of postmarketing cases report gabapentin misuse and abuse. these individuals were taking higher than recommended doses of gabapentin for unapproved uses. most of the individuals described in these reports had a history of poly-substance abuse or used gabapentin to relieve symptoms of withdrawal from other substances. when prescrib
apo-rabeprazole 10mg tablets enteric-coated
apotex inc. - rabeprazole (rabeprazole sodium) - tablets enteric-coated - 10mg
apo-rabeprazole 20mg tablets enteric-coated
apotex inc. - rabeprazole (rabeprazole sodium) - tablets enteric-coated - 20mg
apo-amoxi clav 875mg+125mg tablets
apotex inc. - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - tablets - 875mg+125mg
apo-amoxi clav 250mg+125mg tablets
apotex inc. - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - tablets - 250mg+125mg
apo-amoxi clav 500mg+125mg tablets
apotex inc. - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - tablets - 500mg+125mg
olopatadine hydrochloride solution/ drops
apotex corp. - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine hydrochloride ophthalmic solution, 0.1% is indicated for the treatment of the signs and symptoms of allergic conjunctivitis. olopatadine hydrochloride ophthalmic solution, 0.1 % is contraindicated in persons with a known hypersensitivity to olopatadine hydrochloride or any components of olopatadine hydrochloride ophthalmic solution, 0.1%.